Navigation Links
MEDRAD, Battelle Win Medical Design Excellence Award for MEDRAD XDS(TM) Extravasation Detector
Date:4/8/2008

Medical Design Excellence Awards is the Premier Award Program for Medical Technology

COLUMBUS, Ohio, April 8, 2008 /PRNewswire-USNewswire/ -- MEDRAD, Inc. and Battelle, the world's largest non-profit independent research and development organization, today announced the winning of a Medical Design Excellence Award (MDEA) for the MEDRAD XDS(TM) Extravasation Detector, a technology that enhances the safety of contrast media injection through early detection of extravasations. Extravasation is leakage of fluid, including contrast media, drugs, or solutions, from a vein into the surrounding tissue during intravenous administration.

The MDEA competition is a prestigious program recognizing medical product excellence and the achievements of medical product manufacturers (and the people who are responsible for groundbreaking innovations that are changing the face of healthcare). An impartial, multi-disciplinary panel of jurors with expertise in biomedical engineering, human factors, industrial design, medicine, and diagnostics reviewed the entries and selected the winners.

"We thank MD&DI for this prestigious MDEA that recognizes our XDS Extravasation Detector technology, the investment of many resources for research and development, and the inherent risk of developing medical devices; the MDEA validates that the investment and risk were worth it," said Cliff Kress, senior vice president, MEDRAD CT Business Unit. "We're also proud that we succeeded where others have not in developing an extravasation technology with a major impact on safety and a minor impact on workflow."

Battelle worked closely with MEDRAD to develop the technology from exploration through product development. MEDRAD and Battelle jointly invented the electrical permittivity technology that enables XDS(TM) and developed the commercial product.

XDS(TM) continuously monitors the tissue immediately surrounding and directly beneath the injection site for cha
'/>"/>

SOURCE Battelle
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle
2. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
3. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
4. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
5. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
6. BioMS Medical announces its intention to renew a normal course issuer bid
7. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
8. ATS Medical Expands Open Pivot Heart Valve Offerings
9. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
10. Globus Medical Announces Record 2nd Quarter 2007 Results
11. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Aug. 26, 2014  NeuroSigma, Inc., a ... develop bioelectronic technologies, today announced that it has filed ... Securities and Exchange Commission relating to a proposed initial ... shares to be offered and the price range for ... Jefferies LLC will act as the book-running manager ...
(Date:8/26/2014)... 2014 An analysis by Replikins, Ltd. of ... Mers CoV virus strains has revealed extensive conservation ... This conservation and sharing of specific Replikin gene structures ... candidate, as it did for the H5N1 influenza vaccine ... have been found to be effective (1,2). ...
(Date:8/26/2014)... A team of engineers from Singapore has successfully ... (WSN) for satellite communications. , With the weight ... design, constructing a lightweight, low power-consuming, wireless communication ... satellite has always been a challenge for system ... Research Centre of Nanyang Technological University in Singapore ...
(Date:8/26/2014)... , August 26, 2014 , ... hospitals with surgery validation using its Stratasys Objet24 and Objet30 ... surgery on 3D printed models prior to operations reduces theatre ... effective aid for both patient and surgeon   ... a global leader of 3D printing and additive manufacturing solutions, ...
Breaking Biology Technology:ZigBee in the Sky 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5
... the Board ... Neill Named President, ISELIN, N.J., Jan. 3 Pharmos Corporation,(Nasdaq: ... effective immediately., Board Changes, Robert F. Johnston has been elected ... and Mony Ben Dor have retired from,the Board., The Pharmos Board ...
... Jan. 3 Cambrex,Corporation (NYSE: CBM ) ... President and Chief Executive Officer, will make a ... on January 8, 2008 at,9:00 a.m. PST at ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO ), A live ...
... Manufacture; Genzyme will Continue to Market and ... ... CAMBRIDGE, Mass., Jan. 3 ,BioMarin Pharmaceutical Inc. (Nasdaq and SWX: ... restructuring of their joint venture,regarding Aldurazyme(R) (laronidase). Under the revised ...
Cached Biology Technology:Pharmos Corporation Announces Board and Management Changes 2Pharmos Corporation Announces Board and Management Changes 3BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 2BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 3BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 4BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 5
(Date:8/25/2014)... study reveals that the US has experienced widespread ... prostate cancer in recent years. The BJU ... surgeries are more expensive than traditional surgeries, their ... surgeons began using robotic technologies in operations to ... use of such robotic-assisted radical prostatectomy (RARP) procedures ...
(Date:8/25/2014)... of the most widespread causes of reduced crop yield. ... are plagued by boron deficient soil and, often, corn ... with boron; however, little is known about the ways ... researchers at the University of Missouri have found that ... in corn plants. Scientists anticipate that understanding how corn ...
(Date:8/25/2014)... promotes virus entry into cells also has the ability ... University of Missouri researchers have found. , "This is ... understanding of not only HIV infection, but also that ... Ph.D., associate professor in the MU School of Medicine,s ... was recently published in the Proceedings of the ...
Breaking Biology News(10 mins):US has seen widespread adoption of robot-assisted cancer surgery to remove the prostate 2Researchers find boron facilitates stem cell growth and development in corn 2MU researchers discover protein's ability to inhibit HIV release 2MU researchers discover protein's ability to inhibit HIV release 3
... system, every protein made in the cell has a specific ... proteins to their appropriate target. Researchers at Boston University ... images of these channels as they open to allow proteins ... made. These findings are published as a Letter in ...
... apps, cameras, and mobile internet to navigate strange cities in ... in line, and upload their videos directly to social media ... high-tech savvy can save a well-loved device from dying when ... same basic ailment that plagues solar power plants and wind ...
... A drug currently on the market to treat leukemia reversed ... findings by medical researchers with the University of Alberta. ... team,s discovery in the peer-reviewed journal, PLOS ONE . ... can also play an important role in the development of ...
Cached Biology News:Researchers capture images of open channel that moves proteins across cell membranes 2Futuristic copper foam batteries get more bang for the buck 2Futuristic copper foam batteries get more bang for the buck 3UAlberta medical researchers discover potential new treatment for colitis 2UAlberta medical researchers discover potential new treatment for colitis 3
Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
GOAT ANTI FRK...
UV LAMP 300 NM 8W T5, 1 EA. Category: Nucleid Acid Detection Systems....
Biology Products: